8-K Announcements
6Material company update
Mar 27, 2026·SEC
Material company update
Mar 27, 2026·SEC
Material company update
Mar 26, 2026·SEC
Health In Tech, Inc.(HIT)Earnings, Financials & Key Ratios
HIT•NASDAQ
$1.52
$82M mkt cap·76.0× P/E·Price updated May 6, 2026
AboutHealth In Tech, Inc. operates as an insurance technology platform company. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small to medium sized employers. It also provides health intelligence (HI) card to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.Show more
- Revenue$33M+71.0%
- EBITDA$2M+58.7%
- Net Income$1M+90.7%
- EPS (Diluted)0.02+62.6%
- Gross Margin62.82%-20.7%
- EBITDA Margin7.29%-7.2%
- Operating Margin4.59%-9.7%
- Net Margin3.84%+11.5%
- ROE8.45%+21.3%
- ROIC15.17%+13.6%
- Debt/Equity0.01-47.9%
HIT Key Insights
Health In Tech, Inc. (HIT) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Excellent 3Y average ROE of 27.1%
- ✓High quality earnings: Operating CF exceeds net income
- ✓Efficient asset utilization: 1.4x turnover
✗Weaknesses
- ✗Negative free cash flow
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
HIT Price & Volume
Health In Tech, Inc. (HIT) stock price & volume — 10-year historical chart
Loading chart...
HIT Growth Metrics
Health In Tech, Inc. (HIT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years79.42%
TTM70.99%
Profit CAGR
10 Years-
5 Years-
3 Years152.18%
TTM90.74%
EPS CAGR
10 Years-
5 Years-
3 Years137.13%
TTM60%
Return on Capital
10 Years21.01%
5 Years21.01%
3 Years26.5%
Last Year9.68%
HIT Peer Comparison
Health In Tech, Inc. (HIT) competitors in Financial services and insurance software — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HIMS | 6.94B | 26.88 | 52.71 | 59% | 5.47% | 23.73% | 2.07 | |
 GDRX | 880.73M | 2.57 | 30.13 | 0.57% | 3.74% | 4.75% | 0.10 | |
 EVLV | 1.25B | 7.11 | -35.55 | 40.48% | -22.71% | -30.45% | 0.35 | |
 OSCR | 5.14B | 19.84 | -11.74 | 27.5% | -0.3% | -3.26% | 0.44 | |
 CLVT | 1.78B | 2.78 | -9.27 | -3.97% | -5.62% | -2.81% | 0.92 | |
 ALHC | 3.71B | 18.14 | -4902.70 | 46.06% | 0.47% | 11.5% | 1.89 | |
 BHVN | 1.06B | 10.04 | -1.46 | -8.66% | 5.36 | |||
 CLOV | 1.37B | 2.68 | -15.76 | 40.34% | -2.58% | -17.08% |
Compare HIT vs Peers
Health In Tech, Inc. (HIT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
HIT Income Statement
Health In Tech, Inc. (HIT) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|
| Sales/Revenue | 5.77M | 19.15M | 19.49M | 33.33M |
| Revenue Growth % | - | 231.93% | 1.77% | 70.99% |
| Cost of Goods Sold | 334.19K | 2.3M | 4.05M | 12.39M |
| COGS % of Revenue | 5.79% | 12.03% | 20.79% | 37.18% |
| Gross Profit | 5.44M▲ 0% | 16.85M▲ 209.9% | 15.44M▼ 8.4% | 20.94M▲ 35.6% |
| Gross Margin % | 94.21% | 87.97% | 79.21% | 62.82% |
| Gross Profit Growth % | - | 209.95% | -8.36% | 35.61% |
| Operating Expenses | 5.23M | 13.46M | 14.45M | 19.41M |
| OpEx % of Revenue | 90.64% | 70.31% | 74.13% | 58.24% |
| Selling, General & Admin | 4.44M | 11.46M | 11.64M | 17.84M |
| SG&A % of Revenue | 76.87% | 59.84% | 59.7% | 53.53% |
| Research & Development | 794.62K | 2M | 2.81M | 1.57M |
| R&D % of Revenue | 13.77% | 10.47% | 14.44% | 4.71% |
| Other Operating Expenses | 0 | 0 | 0 | 0 |
| Operating Income | 205.58K▲ 0% | 3.38M▲ 1545.6% | 989.9K▼ 70.7% | 1.53M▲ 54.4% |
| Operating Margin % | 3.56% | 17.66% | 5.08% | 4.59% |
| Operating Income Growth % | - | 1545.62% | -70.74% | 54.4% |
| EBITDA | 205.58K | 3.72M | 1.53M | 2.43M |
| EBITDA Margin % | 3.56% | 19.44% | 7.86% | 7.29% |
| EBITDA Growth % | - | 1710.66% | -58.87% | 58.65% |
| D&A (Non-Cash Add-back) | 0 | 339.3K | 541.14K | 900.58K |
| EBIT | 205.58K | 3.42M | 1.38M | 1.67M |
| Net Interest Income | -4.57K | 38.8K | -372.12K | 409.92K |
| Interest Income | 0 | 40.86K | 122.89K | 409.92K |
| Interest Expense | 4.57K | 2.05K | 495K | 0 |
| Other Income/Expense | -4.57K | 38.8K | -100.9K | 145.73K |
| Pretax Income | 201.01K▲ 0% | 3.42M▲ 1602.4% | 889K▼ 74.0% | 1.67M▲ 88.3% |
| Pretax Margin % | 3.48% | 17.87% | 4.56% | 5.02% |
| Income Tax | 121.27K | 945.24K | 218.52K | 395.33K |
| Effective Tax Rate % | 60.33% | 27.62% | 24.58% | 23.61% |
| Net Income | 79.74K▲ 0% | 2.48M▲ 3005.8% | 670.48K▼ 72.9% | 1.28M▲ 90.7% |
| Net Margin % | 1.38% | 12.93% | 3.44% | 3.84% |
| Net Income Growth % | - | 3005.84% | -72.93% | 90.74% |
| Net Income (Continuing) | 79.74K | 2.48M | 670.48K | 1.28M |
| Discontinued Operations | 0 | 0 | 0 | 0 |
| Minority Interest | 367.77K | 0 | 0 | 0 |
| EPS (Diluted) | 0.00▲ 0% | 0.05▲ 2953.3% | 0.01▼ 73.1% | 0.02▲ 62.6% |
| EPS Growth % | - | - | -73.14% | 62.6% |
| EPS (Basic) | 0.00 | 0.05 | 0.01 | 0.02 |
| Diluted Shares Outstanding | 54.07M | 54.07M | 53.66M | 57.74M |
| Basic Shares Outstanding | 54.07M | 54.07M | 67.05M | 55.84M |
| Dividend Payout Ratio | - | - | - | - |
HIT Balance Sheet
Health In Tech, Inc. (HIT) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|
| Total Current Assets | 25.43M | 6.86M | 10.78M | 16.16M |
| Cash & Short-Term Investments | 1.49M | 2.42M | 7.85M | 7.67M |
| Cash Only | 1.49M | 2.42M | 7.85M | 7.67M |
| Short-Term Investments | 0 | 0 | 0 | 0 |
| Accounts Receivable | 976.86K | 3.92M | 2.15M | 756.29K |
| Days Sales Outstanding | 61.8 | 74.65 | 40.21 | 8.28 |
| Inventory | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - |
| Other Current Assets | 22.96M | 526.15K | 787.16K | 7.73M |
| Total Non-Current Assets | 3.13M | 4.64M | 4.98M | 6.93M |
| Property, Plant & Equipment | 321.81K | 266.64K | 206.27K | 139.94K |
| Fixed Asset Turnover | 17.93x | 71.83x | 94.49x | 238.16x |
| Goodwill | 0 | 0 | 0 | 0 |
| Intangible Assets | 2.76M | 3.56M | 3.96M | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 48.23K | 816K | 816K | 6.79M |
| Total Assets | 28.56M▲ 0% | 11.5M▼ 59.7% | 15.77M▲ 37.1% | 23.09M▲ 46.4% |
| Asset Turnover | 0.20x | 1.66x | 1.24x | 1.44x |
| Asset Growth % | - | -59.72% | 37.08% | 46.43% |
| Total Current Liabilities | 24.02M | 4.78M | 2.13M | 5.16M |
| Accounts Payable | 474.39K | 2.62M | 1.86M | 0 |
| Days Payables Outstanding | 518.13 | 415.23 | 167.47 | - |
| Short-Term Debt | 0 | 1.65M | 0 | 76.19K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 23.37M | 0 | 0 | 5.08M |
| Current Ratio | 1.06x | 1.43x | 5.06x | 3.13x |
| Quick Ratio | 1.06x | 1.43x | 5.06x | 3.13x |
| Cash Conversion Cycle | - | - | - | - |
| Total Non-Current Liabilities | 3.12M | 628.67K | 468.49K | 821.29K |
| Long-Term Debt | 0 | 0 | 0 | 63.62K |
| Capital Lease Obligations | 265.37K | 206.69K | 139.81K | 0 |
| Deferred Tax Liabilities | 288K | 421.98K | 328.68K | 757.67K |
| Other Non-Current Liabilities | 2.57M | 0 | 0 | 0 |
| Total Liabilities | 27.14M | 5.41M | 2.6M | 5.98M |
| Total Debt | 316.09K | 1.92M | 206.69K | 139.81K |
| Net Debt | -1.17M | -501.18K | -7.64M | -7.53M |
| Debt / Equity | 0.22x | 0.31x | 0.02x | 0.01x |
| Debt / EBITDA | 1.54x | 0.51x | 0.14x | 0.06x |
| Net Debt / EBITDA | -5.70x | -0.13x | -4.99x | -3.10x |
| Interest Coverage | 44.97x | 1668.59x | 2.80x | - |
| Total Equity | 1.42M▲ 0% | 6.09M▲ 329.6% | 13.17M▲ 116.1% | 17.11M▲ 29.9% |
| Equity Growth % | - | 329.62% | 116.13% | 29.94% |
| Book Value per Share | 0.03 | 0.11 | 0.25 | 0.30 |
| Total Shareholders' Equity | 1.05M | 6.09M | 13.17M | 17.11M |
| Common Stock | 45K | 51.77K | 54.62K | 57.71K |
| Retained Earnings | 794.26K | 3.27M | 3.94M | 5.22M |
| Treasury Stock | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 |
| Minority Interest | 367.77K | 0 | 0 | 0 |
HIT Cash Flow Statement
Health In Tech, Inc. (HIT) cash flow — operating, investing & free cash flow history
| Line item | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|
| Cash from Operations | 782.75K | 1.53M | 2.18M | 3.13M |
| Operating CF Margin % | 13.57% | 7.98% | 11.17% | 9.4% |
| Operating CF Growth % | - | 95.32% | 42.34% | 44% |
| Net Income | -243.34K | 3.96M | 670.48K | 1.28M |
| Depreciation & Amortization | 0 | 339.3K | 541.14K | 900.58K |
| Stock-Based Compensation | 566.04K | 0 | 468.49K | 1.57M |
| Deferred Taxes | 9K | 133.98K | -93.3K | 429K |
| Other Non-Cash Items | 0 | -16K | 432.88K | 4.19M |
| Working Capital Changes | 451.06K | -2.89M | 156.52K | -5.23M |
| Change in Receivables | -716K | -2.94M | 1.77M | -2.44M |
| Change in Inventory | 0 | 0 | 0 | 0 |
| Change in Payables | 449.95K | 2.15M | -851.96K | 2.36M |
| Cash from Investing | -1.22M | -1.94M | -836.75K | -3.13M |
| Capital Expenditures | -1.22M | -1.14M | -900.75K | 0 |
| CapEx % of Revenue | 21.13% | 5.98% | 4.62% | 9.57% |
| Acquisitions | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - |
| Other Investing | 0 | -800K | 64K | -3.13M |
| Cash from Financing | 1.88M | 1.34M | 4.09M | -187.39K |
| Debt Issued (Net) | -74.09K | 1.65M | -2.15M | 0 |
| Equity Issued (Net) | 2M | 0 | 8.21M | 23.43K |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 |
| Other Financing | -46.97K | -306.12K | -1.98M | -210.82K |
| Net Change in Cash | 1.44M▲ 0% | 928.4K▼ 35.6% | 5.43M▲ 485.2% | -179.49K▼ 103.3% |
| Free Cash Flow | -436.63K▲ 0% | 384.52K▲ 188.1% | 1.28M▲ 231.7% | -56.11K▼ 104.4% |
| FCF Margin % | -7.57% | 2.01% | 6.54% | -0.17% |
| FCF Growth % | - | 188.07% | 231.7% | -104.4% |
| FCF per Share | -0.01 | 0.01 | 0.02 | -0.00 |
| FCF Conversion (FCF/Net Income) | 9.82x | 0.62x | 3.25x | 2.45x |
| Interest Paid | 4.57K | 2.05K | 0 | 0 |
| Taxes Paid | 0 | 479.21K | 558.52K | 830.73K |
HIT Key Ratios
Health In Tech, Inc. (HIT) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Return on Equity (ROE) | 5.62% | 65.94% | 6.96% | 8.45% |
| Return on Invested Capital (ROIC) | 62.57% | 86.92% | 13.35% | 15.17% |
| Gross Margin | 94.21% | 87.97% | 79.21% | 62.82% |
| Net Margin | 1.38% | 12.93% | 3.44% | 3.84% |
| Debt / Equity | 0.22x | 0.31x | 0.02x | 0.01x |
| Interest Coverage | 44.97x | 1668.59x | 2.80x | - |
| FCF Conversion | 9.82x | 0.62x | 3.25x | 2.45x |
| Revenue Growth | - | 231.93% | 1.77% | 70.99% |
HIT SEC Filings & Documents
Health In Tech, Inc. (HIT) SEC filings — annual & quarterly reports (10-K, 10-Q)
HIT Frequently Asked Questions
Health In Tech, Inc. (HIT) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Health In Tech, Inc. (HIT) reported $33.3M in revenue for fiscal year 2025. This represents a 478% increase from $5.8M in 2022.
Health In Tech, Inc. (HIT) grew revenue by 71.0% over the past year. This is strong growth.
Yes, Health In Tech, Inc. (HIT) is profitable, generating $1.3M in net income for fiscal year 2025 (3.8% net margin).
Dividend & Returns
Health In Tech, Inc. (HIT) has a return on equity (ROE) of 8.4%. This is below average, suggesting room for improvement.
Health In Tech, Inc. (HIT) had negative free cash flow of $5.22T in fiscal year 2025, likely due to heavy capital investments.
Explore More HIT
Health In Tech, Inc. (HIT) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates